William Mann, PhD, MBA
William (Bill) Mann’s expertise includes discovery research, product development, business development, strategic planning, and commercial operations. He leverages these competencies, together with a wide network and a focus on collaboration, to deliver innovative and actionable solutions to his clients.
Before establishing Lodestar, Bill was president and CEO of Helsinn Therapeutics (U.S.), Inc, where he led the company’s transformation from R&D to commercial profitability.
Prior to Helsinn, he was VP of business development at Sapphire Therapeutics, Inc. and also led the company’s primary clinical Phase 2 program. At Novartis, Bill held leadership positions in discovery research and global business development and served on one of the company’s global business franchise boards.